Vext Science Inc
CNSX:VEXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Vext Science Inc
Note Receivable
Vext Science Inc
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Vext Science Inc
CNSX:VEXT
|
Note Receivable
$1.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Note Receivable
$20.8m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Note Receivable
CA$45.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Vext Science Inc
Glance View
Vext Science, Inc. engages in the cultivation, extraction, and wholesale distribution of cannabis products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-05-13. The firm utilizes a vertical integration business model to execute all aspects of cultivation, extraction, manufacturing (tetrahydrocannabinol (THC) and cannabidiol (CBD) cartridges, concentrates, edibles), retail dispensary, and wholesale distribution of cannabis THC and hemp CBD products. The company provides these management and marketing services in Arizona to two licensed dispensaries. The firm has developed a standard operating procedures (SOPs) to produce a full line of branded flower, Vapen branded THC and CBD distillates, concentrates, extracts, and edibles. The company operates a service business for cannabis cultivation and processing located in the State of Arizona. The firm's products produced under contract are sold through Herbal Wellness Center and Organica Patient Group Medical Marijuana Dispensary, both licensed not-for-profit dispensaries located in Phoenix, Arizona.
See Also
What is Vext Science Inc's Note Receivable?
Note Receivable
1.4m
USD
Based on the financial report for Sep 30, 2025, Vext Science Inc's Note Receivable amounts to 1.4m USD.
What is Vext Science Inc's Note Receivable growth rate?
Note Receivable CAGR 5Y
-27%
Over the last year, the Note Receivable growth was 2%. The average annual Note Receivable growth rates for Vext Science Inc have been 1% over the past three years , -27% over the past five years .
